Literature DB >> 3257251

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.

N L Vujanovic1, R B Herberman, A A Maghazachi, J C Hiserodt.   

Abstract

A simple method for the purification and rapid expansion of large granular lymphocytes into cells with efficient broad antitumor cytotoxicity after stimulation by human rIL-2 is described. Nylon-wool nonadherent splenic mononuclear leukocytes from Fischer 344 rats were cultured in medium containing 1,000 U/ml rIL-2. The initial response of a small subpopulation of cells (less than 2%) to rIL-2 was their adherence to the plastic surface. This response was noted as soon as 2 h after addition of rIL-2. 2-h rIL-2-activated plastic adherent lymphocytes were 90-98% LGL, expressed surface markers characteristic of rat NK cells (OX8 [CD8]+, asialo GM1, laminin+, OX19 [CD5]-, R1-3B3 [CD5]-, W3/25 [CD4]-, OX39 [CD25]-, Ia-, and Ig-), and expressed very high levels of cytotoxicity against YAC-1 target cells. In addition to the above markers, plastic-adherent LGLs obtained at 24, 48, or 72 h progressively expressed Ia surface antigens, but were not phagocytic and contained less than 1% monocytes/macrophages by morphology. When 24- or 48-h plastic-adherent LGL/NK cells were cultured over 3-4 d in rIL-2, the cells expanded between 30- and 100-fold, reaching densities between 2-3 X 10(6) cells/ml. These rapidly expanding LGL/NK cells also generated very high levels of LAK activity (including lysis of fresh NK-resistant solid tumor cells), expressed a phenotype characteristic of activated rat NK/LAK cells, and incorporated [3H]TdR into DNA. This technique not only provides a novel method for the purification of LGL/NK cells for in vitro studies but also provides a means for the rapid expansion of highly purified cells with high levels of broad antitumor (LAK) cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257251      PMCID: PMC2188812          DOI: 10.1084/jem.167.1.15

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells.

Authors:  H O Sjögren; I Hellström
Journal:  Exp Cell Res       Date:  1965-10       Impact factor: 3.905

Review 2.  Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.

Authors:  S A Rosenberg; M T Lotze
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

3.  Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells.

Authors:  J C Hiserodt; K A Laybourn; J Varani
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

4.  Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.

Authors:  K Itoh; A B Tilden; K Kumagai; C M Balch
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

5.  Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells.

Authors:  C W Reynolds; T Timonen; R B Herberman
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

6.  Phorbol ester-induced lymphocyte adherence: selective action on NK cells.

Authors:  S Argov; M Hebdon; P Cuatrecasas; H S Koren
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

7.  Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

Authors:  T Barlozzari; J Leonhardt; R H Wiltrout; R B Herberman; C W Reynolds
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

8.  Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.

Authors:  L L Lanier; C J Benike; J H Phillips; E G Engleman
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

9.  Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.

Authors:  J C Yang; J J Mulé; S A Rosenberg
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

10.  Lymphokine-activated killer cells. Analysis of progenitors and effectors.

Authors:  J R Ortaldo; A Mason; R Overton
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  27 in total

1.  Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.

Authors:  C A Kruse; K O Lillehei; D H Mitchell; B Kleinschmidt-DeMasters; D Bellgrau
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells.

Authors:  G M Bell; J B Bolen; J B Imboden
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

3.  Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels.

Authors:  P Basse; R B Herberman; M Hokland; R H Goldfarb
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  CD161B:ClrB interactions mediate activation of enhanced lysis of tumor target cells following NK cell:DC co-culture.

Authors:  Tianbing Yang; Melanie S Flint; Katie M Webb; William H Chambers
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.

Authors:  Seiji Goda; Hiroshi Inoue; Hisanori Umehara; Michihiko Miyaji; Yutaka Nagano; Nari Harakawa; Hisao Imai; Peter Lee; James B Macarthy; Takashi Ikeo; Naochika Domae; Yoji Shimizu; Joji Iida
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

6.  Large-scale preparation of adherent lymphokine-activated killer (A-LAK) cells for adoptive immunotherapy in man.

Authors:  R J Melder; C S Rosenfeld; R B Herberman; T L Whiteside
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Differential effects of various cytokines on the generation of rat LAK cells from their purified precursors.

Authors:  A A Maghazachi
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

8.  Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cells.

Authors:  L Kiremidjian-Schumacher; M Roy; H I Wishe; M W Cohen; G Stotzky
Journal:  Biol Trace Elem Res       Date:  1996-06       Impact factor: 3.738

9.  Drug resistance in rat colon cancer cell lines is associated with minor changes in susceptibility to cytotoxic cells.

Authors:  W Van de Vrie; S A Van der Heyden; E E Gheuens; A M Bijma; E A De Bruijn; R L Marquet; A T Van Oosterom; A M Eggermont
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

10.  Fate of intravenously administered rat lymphokine-activated killer cells labeled with different markers.

Authors:  A A Maghazachi; L Fitzgibbon
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.